Lysophosphatidic acid type 2 receptor agonists in targeted drug development offer broad therapeutic potential

The growth factor-like lipid mediator, lysophosphatidic acid (LPA), is a potent signaling molecule that influences numerous physiologic and pathologic processes. Manipulation of LPA signaling is of growing pharmacotherapeutic interest, especially because LPA resembles compounds with drug-like featur...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Lipid Res
Главные авторы: Tigyi, Gabor J., Johnson, Leonard R., Lee, Sue Chin, Norman, Derek D., Szabo, Erzsebet, Balogh, Andrea, Thompson, Karin, Boler, Alyssa, McCool, W. Shannon
Формат: Artigo
Язык:Inglês
Опубликовано: The American Society for Biochemistry and Molecular Biology 2019
Предметы:
JLR Perspectives
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6399510/
https://ncbi.nlm.nih.gov/pubmed/30692142
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1194/jlr.S091744
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы